1. Home
  2. PGY vs PGEN Comparison

PGY vs PGEN Comparison

Compare PGY & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pagaya Technologies Ltd.

PGY

Pagaya Technologies Ltd.

HOLD

Current Price

$21.80

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$6.64

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGY
PGEN
Founded
2016
1998
Country
United States
United States
Employees
511
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
PGY
PGEN
Price
$21.80
$6.64
Analyst Decision
Strong Buy
Buy
Analyst Count
8
5
Target Price
$34.50
$8.33
AVG Volume (30 Days)
3.1M
4.0M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$230,981,000.00
Revenue This Year
$14.27
$1,115.92
Revenue Next Year
$14.39
$81.04
P/E Ratio
$13.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.40
$1.70
52 Week High
$44.99
$6.70

Technical Indicators

Market Signals
Indicator
PGY
PGEN
Relative Strength Index (RSI) 71.95 72.02
Support Level $20.67 $3.96
Resistance Level $25.47 N/A
Average True Range (ATR) 1.18 0.33
MACD 0.29 0.09
Stochastic Oscillator 98.40 95.64

Price Performance

Historical Comparison
PGY
PGEN

About PGY Pagaya Technologies Ltd.

Pagaya Technologies Ltd is a product-focused technology company. It uses machine learning, a vast data network, and an AI-driven approach to offer comprehensive consumer credit and residential real estate products for its partners, their customers, and investors. Its suite of products includes Decline Monetization, Dual Look, First Look, Affiliate Optimizer Engine, Direct Marketing Engine, and FastPass, providing lenders with an AI-powered credit and acquisition ecosystem that helps them approve more borrowers, capture more demand, and grow without adding risk. Geographically, the company generates maximum revenue from its business in the United States.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: